Trial Condition(s):
Contraception
Yasmin Post Marketing Surveillance
Bayer Identifier:
14339
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Study Completed
Trial Purpose
The objective of this Post Marketing Surveillance (PMS) is to gain information about safety and efficacy in real practice.
Inclusion Criteria
- Women who need oral contraceptive
Exclusion Criteria
- Patient who belongs to contraindication listed on the product label.
Trial Summary
Enrollment Goal
777
Trial Dates
Phase
N/A
Could I receive a placebo?
No
Products
Yasmin (EE30/DRSP, BAY86-5131)
Accepts Healthy Volunteers
No
Where to Participate
Loading...
Locations
| Locations | |
|---|---|
Locations Investigative Site Many Locations, South Korea | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Yasmin regulatory Post Marketing Surveillance
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Safety and efficacy in real practiceTimeframe: After 6 cycle of treatment
Secondary Outcome
- DemographyTimeframe: At initial visit
- Medical HistoryTimeframe: At initial visit
- Administration period of YasminTimeframe: After 6 cycle of treatment or at the point of withdrawan
- Patient's complianceTimeframe: After 6 cycle of treatment or at the point of withdrawan
- Adverse Event / Serious AE collectionTimeframe: At point of the occurence
Additional Information
Copyright © Bayer
Powered by
